The global pneumatic tourniquet market size was estimated to be USD 0.439 billion in 2023 and is expected to reach at USD 1.01 billion by 2034 with a CAGR of 7.84% during the forecast period 2024-2034. A rising number of orthopedic and plastic surgeries, an increase in accidental injuries and falls, a surge in the prevalence of degenerative bone diseases, a growing burden of accident-related emergency admissions, an escalating demand for wound care surgeries, a notable increase in acquisitions and strategic initiatives by major market players, a rise in the geriatric population, heightened patient awareness, an increasing occurrence of sports injuries, and a growing introduction of innovative pneumatic tourniquet products are some of the key factors boosting the market growth.
A growing introduction of innovative pneumatic tourniquet products is predicted to boost the market growth during the forecast period. In orthopedic and plastic surgeries, pneumatic tourniquets are employed to establish a bloodless field, providing superior safety and enhanced precision for the surgeon. For instance, in September 2022, Boon Edam has officially introduced BE Secure, a novel secure top sensing system designed for application with Turnlock full-height tourniquets.
By type, single bladder was the highest revenue-grossing segment in the global pneumatic tourniquet market in 2023 owing to the growing number of orthopedic surgeries being conducted, an increase in cases of accidental injuries, and a rising trend in the introduction of new products. These products offer standardized pressure control and compression, irrespective of the strength and position of a medical expert's hand. Many tourniquet cuffs in the market typically feature a single pneumatic bladder, minimizing post-surgery pain and complications, ultimately leading to enhanced clinical efficacy and a consequent high demand for these products. For instance, in June 2023, SourceMark Medical, a certified Minority Business Enterprise (MBE) and medical device company based in the United States, unveiled an extensive range of self-branded disposable pneumatic tourniquet cuffs, available in both single- and dual-port configurations. Additionally, dual bladder is predicted to grow at the fastest CAGR during the forecast period. Cuffs primarily crafted for intravenous regional anesthesia are equipped with a dual bladder. This design allows independent control of inflation and deflation for each bladder, enabling anesthesia professionals to manage patient pain effectively and enhance overall patient comfort.
By application, orthopedic surgery was the highest revenue-grossing segment in the global pneumatic tourniquet market in 2023 owing to a rise in orthopedic conditions and other degenerative bone diseases, an increasing demand for improved surgical care, a growing incidence of target conditions like osteoarthritis, and increase in knee and hip replacement surgeries. Additionally, plastic surgery is predicted to grow at the fastest CAGR during the forecast period owing to the rising number of accident cases, an increasing demand for minimally invasive surgeries, and a surge in collaborations among market players. For instance, in December 2022, Brown Gibbons Lang & Company (BGL), a well-known investment banking and financial advisory firm, is excited to reveal a recent agreement with Synergy Plastic Surgery. Synergy Plastic Surgery consists of twelve providers, and it is led by six esteemed plastic surgeons who are board-certified.
North America region is anticipated for the highest revenue share during the forecast period owing to the demographic shift toward an increasing geriatric population, the continual development of healthcare infrastructure, a growing burden of orthopedic and other diseases, heightened investments in the expansion and construction of hospitals, a heightened focus on the customization of innovative devices through technological advancements, and an escalating adoption of minimally invasive surgeries. For instance, in August 2022, SourceMark Medical, recognized as a certified Minority Business Enterprise (MBE) in the U.S., has recently secured an agreement for its Tourniquet Touch Pneumatic Tourniquet system with Premier, Inc. Premier is a healthcare improvement company that unites around 4,400 hospitals and health systems in the United States, along with over 250,000 other providers and organizations. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the growing number of upper and lower limb surgeries being conducted, an increasing inclination towards clinical trials, substantial research and development investments by market players due to the cost-effectiveness, a high prevalence of degenerative bone diseases, a rise in orthopedic surgeries, and surge in government initiatives. In April 2022, The Food and Drug Administration (FDA) has recently revised the Product Classification page related to pneumatic tourniquets. The update specifies that if a manufacturer's device falls within a generic category of exempted class I devices, as outlined in 21 CFR Parts 862-892, there is no need for a premarket notification application or FDA clearance before marketing the device in the United States. However, these manufacturers are obligated to register their establishment.
A growing introduction of innovative pneumatic tourniquet products is predicted to boost the market growth during the forecast period. In orthopedic and plastic surgeries, pneumatic tourniquets are employed to establish a bloodless field, providing superior safety and enhanced precision for the surgeon. For instance, in September 2022, Boon Edam has officially introduced BE Secure, a novel secure top sensing system designed for application with Turnlock full-height tourniquets.
By type, single bladder was the highest revenue-grossing segment in the global pneumatic tourniquet market in 2023 owing to the growing number of orthopedic surgeries being conducted, an increase in cases of accidental injuries, and a rising trend in the introduction of new products. These products offer standardized pressure control and compression, irrespective of the strength and position of a medical expert's hand. Many tourniquet cuffs in the market typically feature a single pneumatic bladder, minimizing post-surgery pain and complications, ultimately leading to enhanced clinical efficacy and a consequent high demand for these products. For instance, in June 2023, SourceMark Medical, a certified Minority Business Enterprise (MBE) and medical device company based in the United States, unveiled an extensive range of self-branded disposable pneumatic tourniquet cuffs, available in both single- and dual-port configurations. Additionally, dual bladder is predicted to grow at the fastest CAGR during the forecast period. Cuffs primarily crafted for intravenous regional anesthesia are equipped with a dual bladder. This design allows independent control of inflation and deflation for each bladder, enabling anesthesia professionals to manage patient pain effectively and enhance overall patient comfort.
By application, orthopedic surgery was the highest revenue-grossing segment in the global pneumatic tourniquet market in 2023 owing to a rise in orthopedic conditions and other degenerative bone diseases, an increasing demand for improved surgical care, a growing incidence of target conditions like osteoarthritis, and increase in knee and hip replacement surgeries. Additionally, plastic surgery is predicted to grow at the fastest CAGR during the forecast period owing to the rising number of accident cases, an increasing demand for minimally invasive surgeries, and a surge in collaborations among market players. For instance, in December 2022, Brown Gibbons Lang & Company (BGL), a well-known investment banking and financial advisory firm, is excited to reveal a recent agreement with Synergy Plastic Surgery. Synergy Plastic Surgery consists of twelve providers, and it is led by six esteemed plastic surgeons who are board-certified.
North America region is anticipated for the highest revenue share during the forecast period owing to the demographic shift toward an increasing geriatric population, the continual development of healthcare infrastructure, a growing burden of orthopedic and other diseases, heightened investments in the expansion and construction of hospitals, a heightened focus on the customization of innovative devices through technological advancements, and an escalating adoption of minimally invasive surgeries. For instance, in August 2022, SourceMark Medical, recognized as a certified Minority Business Enterprise (MBE) in the U.S., has recently secured an agreement for its Tourniquet Touch Pneumatic Tourniquet system with Premier, Inc. Premier is a healthcare improvement company that unites around 4,400 hospitals and health systems in the United States, along with over 250,000 other providers and organizations. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the growing number of upper and lower limb surgeries being conducted, an increasing inclination towards clinical trials, substantial research and development investments by market players due to the cost-effectiveness, a high prevalence of degenerative bone diseases, a rise in orthopedic surgeries, and surge in government initiatives. In April 2022, The Food and Drug Administration (FDA) has recently revised the Product Classification page related to pneumatic tourniquets. The update specifies that if a manufacturer's device falls within a generic category of exempted class I devices, as outlined in 21 CFR Parts 862-892, there is no need for a premarket notification application or FDA clearance before marketing the device in the United States. However, these manufacturers are obligated to register their establishment.
Segmentation: Pneumatic Tourniquet Market Report 2023 - 2034
Pneumatic Tourniquet Market Analysis & Forecast by Type 2023 - 2034 (Revenue USD Bn)
- Dual Bladder
- Single Bladder
Pneumatic Tourniquet Market Analysis & Forecast by Application 2023 - 2034 (Revenue USD Bn)
- Plastic Surgery
- Orthopedic Surgery
- Others
Pneumatic Tourniquet Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Pneumatic Tourniquet Market: Type Estimates & Trend Analysis
8. Pneumatic Tourniquet Market: Application Estimates & Trend Analysis
9. Regional Market Analysis
10. North America Pneumatic Tourniquet Market
11. Europe Global Pneumatic Tourniquet Market
12. Asia Pacific Global Pneumatic Tourniquet Market
13. Latin America Global Pneumatic Tourniquet Market
14. MEA Global Pneumatic Tourniquet Market
15. Competitor Analysis
16. Company Profiles
Companies Mentioned
- Jiangsu Qianjing Medical Equipment Co. Ltd
- Dessillions & Dutrillaux (D&D)
- AneticAid
- Stryker
- Hangzhou Kimislab Co. Ltd.
- Ulrich Medical
- VBM Medizintechnik GmbH
- Zimmer Biomet
- DSMAREF Co.Ltd. S.A.ghai Huifeng Medical Instrument Co. Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | March 2024 |
| Forecast Period | 2023 - 2034 |
| Estimated Market Value ( USD | $ 0.44 Billion |
| Forecasted Market Value ( USD | $ 1.01 Billion |
| Compound Annual Growth Rate | 7.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 9 |
